JP2015513527A5 - - Google Patents

Download PDF

Info

Publication number
JP2015513527A5
JP2015513527A5 JP2014556692A JP2014556692A JP2015513527A5 JP 2015513527 A5 JP2015513527 A5 JP 2015513527A5 JP 2014556692 A JP2014556692 A JP 2014556692A JP 2014556692 A JP2014556692 A JP 2014556692A JP 2015513527 A5 JP2015513527 A5 JP 2015513527A5
Authority
JP
Japan
Prior art keywords
protein
peptide
amino acid
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014556692A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015513527A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/025213 external-priority patent/WO2013119863A1/en
Publication of JP2015513527A publication Critical patent/JP2015513527A/ja
Publication of JP2015513527A5 publication Critical patent/JP2015513527A5/ja
Pending legal-status Critical Current

Links

JP2014556692A 2012-02-07 2013-02-07 オオアワガエリアレルゲン並びに免疫応答モジュレーションのための方法及び使用 Pending JP2015513527A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US61/596,156 2012-02-07
US201261734886P 2012-12-07 2012-12-07
US61/734,886 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (2)

Publication Number Publication Date
JP2015513527A JP2015513527A (ja) 2015-05-14
JP2015513527A5 true JP2015513527A5 (enExample) 2016-03-24

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014556692A Pending JP2015513527A (ja) 2012-02-07 2013-02-07 オオアワガエリアレルゲン並びに免疫応答モジュレーションのための方法及び使用

Country Status (13)

Country Link
US (1) US10428124B2 (enExample)
EP (1) EP2812026A4 (enExample)
JP (1) JP2015513527A (enExample)
KR (1) KR20140129124A (enExample)
CN (1) CN104203277A (enExample)
AU (1) AU2013216993C1 (enExample)
BR (1) BR112014019504A2 (enExample)
CA (1) CA2864084A1 (enExample)
EA (1) EA201491481A1 (enExample)
HK (1) HK1204929A1 (enExample)
IN (1) IN2014MN01513A (enExample)
MX (1) MX2014009285A (enExample)
WO (1) WO2013119863A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
EA201691028A1 (ru) 2013-11-20 2017-01-30 Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи Пан-иммуногены пыльцы, способы и применение для модуляции иммунного ответа
CA2933552A1 (en) 2013-12-23 2015-07-02 Alk-Abello A/S Peptide combinations and uses thereof in treating dust mite allergy
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
JP6423889B2 (ja) * 2014-10-07 2018-11-14 サイトリミック株式会社 Hsp70由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法
EP3269733B1 (en) 2015-03-09 2020-06-17 Cytlimic Inc. Peptide derived from gpc3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
US10842848B2 (en) 2015-04-07 2020-11-24 Cytlimic Inc. Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
KR102430856B1 (ko) * 2016-05-03 2022-08-08 에스큐지 바이오테크놀로지스 컴퍼니 관용을 유도하는 생체분자의 세포내 전달
EP3527216B1 (en) 2016-10-11 2024-02-14 NEC Corporation A medicine comprising a toll-like receptor agonist, lag-3 protein, a hsp70-derived peptide and a gpc3-derived peptide
WO2018199341A1 (ja) * 2017-04-28 2018-11-01 学校法人藤田学園 アレルギーの抗原およびそのエピトープ
CN114729929B (zh) * 2019-11-25 2025-10-28 加利福尼亚大学董事会 诊断和治疗自闭症的抗原神经元特异性烯醇化酶肽
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
ES2384045T3 (es) 2002-06-25 2012-06-28 Merck Patent Gmbh Secuencia de ADN y preparación recombinante del alérgeno del polen de gramíneas PHI P 4
AU2003251674B2 (en) * 2002-08-19 2009-09-03 Merck Patent Gmbh Variants of the major allergen Phl p 1 from timothy grass
MXPA05005528A (es) 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
EP3059306A1 (en) * 2005-01-12 2016-08-24 Monsanto Technology LLC Genes and uses for plant improvement
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
ES2950396T3 (es) * 2008-02-01 2023-10-09 Prota Therapeutics Pty Ltd Un método para inducir tolerancia a un alérgeno
EP2388268A1 (en) * 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
KR20130118884A (ko) 2010-10-15 2013-10-30 알크-아벨로 에이/에스 알레르겐 소스 물질로부터 유도된 무관련 알레르겐을 이용한 과민성 면역반응의 억제
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
EP2831102A4 (en) 2012-03-26 2015-12-02 Pronutria Inc NUTRITIONAL FRAGMENTS, PROTEINS THEREFOR AND METHOD
CA2870399A1 (en) 2012-04-16 2013-10-24 Alk-Abello A/S Plant profilin polypeptides for use in non-specific allergy immunotherapy

Similar Documents

Publication Publication Date Title
JP2015513527A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
NZ621868A (en) Growth hormone polypeptides and methods of making and using same
HRP20192314T1 (hr) Pripravci faktora viii i postupci pripreme i njihove uporabe
NZ733168A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
JP2015514395A5 (enExample)
HRP20240226T1 (hr) Pripravci cjepiva koji sadrže protein vezivanja mutiranog faktora h
JP2015525217A5 (enExample)
WO2011113819A3 (en) Diagnosis and treatment of cancer based on avl9
RU2017104529A (ru) Композиции neisseria meningitidis и способы их применения
BRPI0910461B8 (pt) hormônio de estimulação do folículo recombinante, sua composição farmacêutica, seu método de produção e seu uso
HRP20161608T1 (hr) Modificirani tuberkulozni antigeni
EP3363458A3 (en) A peptide
HRP20190982T1 (hr) Peptidi i njihova uporaba
WO2014207708A3 (en) Amino acid and peptide conjugates and conjugation process
RU2015138530A (ru) Комбинированная вакцина против респираторно-синцитиального вируса и вируса гриппа
JP2017536337A5 (enExample)
JP2014058541A5 (enExample)
WO2017145097A3 (en) Amino acid and peptide conjugates and conjugation process
RU2016107873A (ru) Пептиды
WO2013021284A3 (en) Anti-il-6 vaccine composition
NZ596501A (en) Casb7439 constructs
JP2016520534A5 (enExample)
MX2017008406A (es) Conjugados de aminoacidos y peptidos y sus usos.
PH12015502005A1 (en) New stable pentadecapeptide salts, a process for preparation thereof, a use thereof in the manufacture of pharmaceutical preparations and a use thereof in therapy